Personensuche
Personensuche
Es wurde 1 Person gefunden.
14
Funktionen
-
Institutsdirektor/in, Institut für Pharmakologie
Aktuelle Veranstaltungen
-
WiSe 2025
- Kurs Pharmakologie, Toxikologie, Teil II (2. Semester des zweiten Studienabschnitts) (PV)
- Kurs Pharmakologie, Toxikologie, Teil I (1. Semester des zweiten Studienabschnitts) (PV)
- Pharmakologie, Toxikologie, Teil I (Grundlage zum Kurs Pharmakologie, Toxikologie, Teil I) (PV)
- Pharmakologie, Toxikologie, Teil II (Grundlage zum Kurs Pharmakologie, Toxikologie, Teil II)
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
- Kurs Pharmakologie, Toxikologie, Teil I (1. Semester des zweiten Studienabschnitts) (PV)
- Kurs Pharmakologie, Toxikologie, Teil II (2. Semester des zweiten Studienabschnitts) (PV)
- Pharmakologie, Toxikologie, Teil I (Grundlage zum Kurs Pharmakologie, Toxikologie, Teil I)
- Pharmakologie, Toxikologie, Teil II (Grundlage zum Kurs Pharmakologie, Toxikologie, Teil II)
-
WiSe 2024
- Kurs Pharmakologie, Toxikologie, Teil II (2. Semester des zweiten Studienabschnitts) (PV)
- Pharmakologie, Toxikologie, Teil I (Grundlage zum Kurs Pharmakologie, Toxikologie, Teil I) (PV)
- Kurs Pharmakologie, Toxikologie, Teil I (1. Semester des zweiten Studienabschnitts) (PV)
- Pharmakologie, Toxikologie, Teil II (Grundlage zum Kurs Pharmakologie, Toxikologie, Teil II)
- Wahlfach: Molekulare Pharmakologie und Signaltransduktion (WP)
-
SoSe 2024
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
A short history of the atrial NLRP3 inflammasome and its distinct role in atrial fibrillationIn: Journal of Molecular and Cellular Cardiology, Jg. 202, 2025, S. 13 – 23DOI (Open Access)
-
Antithrombotic therapy after coronary artery bypass graft surgery : a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thoracic Surgery (EACTS)In: European Journal of Cardio-Thoracic Surgery, Jg. 67, 2025, Nr. 8, ezaf243DOI (Open Access)
-
Atrial cardiomyocyte-restricted cleavage of gasdermin D promotes atrial arrhythmogenesisIn: European Heart Journal, Jg. 46, 2025, Nr. 13, S. 1250 – 1262DOI (Open Access)
-
Atrial cardiomyopathy : From healthy atria to atrial failure. A clinical consensus statement of the Heart Failure Association of the ESCIn: European Journal of Heart Failure, 2025, in pressDOI (Open Access)
-
Atrial fibrillation burden in clinical practice, research, and technology development : A clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm AssociationIn: EP Europace, Jg. 27, 2025, Nr. 3, euaf019DOI (Open Access)
-
Cardiac magnetic resonance imaging in patients with suspected myocarditis from immune checkpoint inhibitor therapy : A real-world observational studyIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 56, 2025, 101581DOI (Open Access)
-
Ceramides in cardiovascular disease : emerging role as independent risk predictors and novel therapeutic targetsIn: Cardiovascular Research, Jg. 121, 2025, Nr. 9, S. 1345 – 1358DOI (Open Access)
-
Computational modelling of cardiac fibroblast signalling reveals a key role for Ca²⁺ in driving atrial fibrillation-associated fibrosisIn: Journal of Physiology, 2025, in press
-
Computational modelling of the pro- and antiarrhythmic effects of atrial high rate-dependent trafficking of small-conductance calcium-activated potassium channelsIn: Journal of Physiology, 2025, in pressDOI (Open Access)
-
Correction: Thrombin receptor PAR4 cross-activates the tyrosine kinase c-met in atrial cardiomyocytesIn: Naunyn-Schmiedeberg's Archives of Pharmacology, Jg. 398, 2025, Nr. 3, S. 3181 – 3182DOI (Open Access)
-
Correction: Thrombin receptor PAR4 cross‑activates the tyrosine kinase c‑met in atrial cardiomyocytesIn: Naunyn-Schmiedeberg's Archives of Pharmacology, Jg. 398, 2025, Nr. 10, S. 14547 – 14548DOI (Open Access)
-
Critical medications in cardiology : strategic policy of the European Medicines AgencyIn: European Heart Journal, Jg. 46, 2025, Nr. 26, S. 2491 – 2493DOI (Open Access)
-
European Journal of Heart Failure consensus statement : Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to actionIn: European Journal of Heart Failure, 2025, in pressDOI (Open Access)
-
Evaluating artificial intelligence-enabled medical tests in cardiology : Best practiceIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 60, 2025, 101783DOI (Open Access)
-
Fibroblast-Restricted Inflammasome Activation Promotes Atrial Fibrillation and Heart Failure With Diastolic DysfunctionIn: JACC: Basic to Translational Science, Jg. 10, 2025, Nr. 7, 101244DOI (Open Access)
-
From Ca²⁺ dysregulation to heart failure : β-adrenoceptor activation by RKIP postpones molecular damages and subsequent cardiac dysfunction in mice carrying mutant PLNR⁹C by correction of aberrant Ca²⁺-handlingIn: Pharmacological Research, Jg. 211, 2025, 107558DOI (Open Access)
-
Macrophage-mediated IL-6 signaling drives ryanodine receptor–2 calcium leak in postoperative atrial fibrillationIn: The Journal of Clinical Investigation (JCI), Jg. 135, 2025, Nr. 9, e187711DOI (Open Access)
-
Management of dyslipidaemia in patients with comorbidities : facing the challenge: type 1 diabetes mellitusIn: European Heart Journal - Cardiovascular Pharmacotherapy, Jg. 11, 2025, Nr. 4, S. 380 – 386DOI (Open Access)
-
Management of dyslipidaemia in patients with comorbidities : facing the challenge Value and limitations of lipid lowering drugs in liver disease Effects/Interactions of lipid-lowering agents on/with the liverIn: European Heart Journal - Cardiovascular Pharmacotherapy, Jg. 11, 2025, Nr. 2, S. 164 – 173DOI (Open Access)
-
Mechanistic insights into sex differences in atrial electrophysiology and arrhythmia vulnerability through sex-specific computational modelsIn: Journal of Physiology, 2025, in pressDOI (Open Access)
-
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024In: European Heart Journal - Cardiovascular Pharmacotherapy, Jg. 11, 2025, Nr. 3, S. 292 – 317DOI (Open Access)
-
Non-neuronal ventricular cardiomyocyte-located nicotinergic acetylcholine receptors cause remodelling and arrhythmiasIn: European Heart Journal, Jg. 46, 2025, Nr. 13, S. 1247 – 1249
-
Practical compendium of antiarrhythmic drugs : A clinical consensus statement of the European Heart Rhythm Association of the European Society of CardiologyIn: EP Europace, Jg. 27, 2025, Nr. 8, euaf076DOI (Open Access)
-
The diagnostic role of pharmacological provocation testing in cardiac electrophysiology : A clinical consensus statement of the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy, the Association of Paediatric and Congenital Cardiology (AEPC), the Paediatric & Congenital Electrophysiology Society (PACES), the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)In: EP Europace, Jg. 27, 2025, Nr. 4, euaf067DOI (Open Access)
-
Thrombin engages neutrophil-derived secretion products to upregulate interleukin-6 production in atrial cardiomyocytes and the heartIn: Romanian Journal of Cardiology, Jg. 35, 2025, Nr. 3, S. 188 – 193DOI (Open Access)
-
Thrombin receptor PAR4 cross-activates the tyrosine kinase c-met in atrial cardiomyocytesIn: Naunyn-Schmiedeberg's Archives of Pharmacology, Jg. 398, 2025, Nr. 3, S. 2783 – 2796DOI (Open Access)
-
A High-Protein Diet Promotes Atrial Arrhythmogenesis via Absent-in-Melanoma 2 InflammasomeIn: Cells, Jg. 13, 2024, Nr. 2, 108DOI (Open Access)
-
An inflammation resolution–promoting intervention prevents atrial fibrillation caused by left ventricular dysfunctionIn: Cardiovascular Research, Jg. 120, 2024, Nr. 4, S. 345 – 359
-
Atrial cardiomyopathy revisited-evolution of a concept: : a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)In: EP Europace, Jg. 26, 2024, Nr. 9DOI (Open Access)
-
Atrial fibrillation : Pathophysiology, genetic and epigenetic mechanismsIn: The Lancet Regional Health - Europe, Jg. 37, 2024, 100785DOI (Open Access)
-
Correction to: Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paperIn: EP Europace, Jg. 26, 2024, Nr. 6, euae167DOI (Open Access)
-
Delayed ⁶⁸Ga-FAPI-46 PET/MR imaging confirms ongoing fibroblast activation in patients after acute myocardial infarctionIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 50, 2024, 101340DOI (Open Access)
-
Detectable troponin below the 99th percentile predicts survival in patients undergoing coronary angiographyIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 52, 2024, 101419DOI, Online Volltext (Open Access)
-
Direct neuronal protection by the protease-activated receptor PAR4 antagonist ML354 after experimental stroke in miceIn: British Journal of Pharmacology (BJP), Jg. 181, 2024, Nr. 18, S. 3364 – 3379DOI (Open Access)
-
Enhanced Ca²⁺-Driven Arrhythmogenic Events in Female Patients With Atrial Fibrillation: Insights From Computational ModelingIn: JACC Clinical Electrophysiology, Jg. 10, 2024, Nr. 11, S. 2371 – 2391DOI (Open Access)
-
Feasibility of anticoagulation on demand after percutaneous coronary intervention in high-bleeding risk patients with paroxysmal atrial fibrillation : the INTERMITTENT registryIn: European Heart Journal - Digital Health, Jg. 5, 2024, Nr. 5, S. 637 – 642DOI (Open Access)
-
From Atrial Small-conductance Calcium-activated Potassium Channels to New AntiarrhythmicsIn: European Cardiology Review, Jg. 19, 2024, e26DOI (Open Access)
-
Heart failure pharmacotherapy and cancer : Pathways and pre-clinical/clinical evidenceIn: European Heart Journal, Jg. 45, 2024, Nr. 14, S. 1224 – 1240DOI (Open Access)
-
Impact of overweight and obesity on radiation dose and outcome in patients undergoing pulmonary vein isolation by cryoballoon and pulsed field ablationIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 55, 2024, 101516DOI (Open Access)
-
In Vivo Cardiac Electrophysiology in Mice : Determination of Atrial and Ventricular Arrhythmic SubstratesIn: Current Protocols, Jg. 4, 2024, Nr. 2, e994
-
Ischemia does not provoke the full immune training repertoire in human cardiac fibroblastsIn: Naunyn-Schmiedeberg's Archives of Pharmacology, Jg. 397, 2024, Nr. 9, S. 7201 – 7212DOI (Open Access)
-
Longer and better lives for patients with atrial fibrillation : The 9th AFNET/EHRA consensus conferenceIn: EP Europace, Jg. 26, 2024, Nr. 4, euae070DOI (Open Access)
-
Management of dyslipidaemia in patients with comorbidities : Facing the challengeIn: European Heart Journal - Cardiovascular Pharmacotherapy, Jg. 10, 2024, Nr. 7, S. 608 – 613
-
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023In: European Heart Journal - Cardiovascular Pharmacotherapy, Jg. 10, 2024, Nr. 3, S. 219 – 244DOI, Online Volltext (Open Access)
-
Oral anticoagulation in patients with left ventricular thrombus : a systematic review and meta-analysisIn: European Heart Journal - Cardiovascular Pharmacotherapy, Jg. 10, 2024, Nr. 5, S. 444 – 453
-
Outcome after ablation of atypical atrial flutter : Is induction a feasible approach?In: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 54, 2024, 101489DOI (Open Access)
-
Prognostic roles of neutrophil–lymphocyte, monocyte-lymphocyte and platelet-lymphocyte ratios for long-term all-cause mortality in heart failureIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 54, 2024, 101502DOI (Open Access)
-
Red blood cell transfusion and mortality after transcatheter aortic valve implantation via transapical approach : A propensity-matched comparison from the TRITAVI registryIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 53, 2024, 101460DOI (Open Access)
-
Targeting the NLRP3 inflammasome signalling for the management of atrial fibrillationIn: British Journal of Pharmacology (BJP), Jg. 181, 2024, Nr. 24, S. 4939 – 4957DOI (Open Access)
-
The ESC Working Group on cardiovascular pharmacotherapy : Continuity through transformationIn: European Heart Journal - Cardiovascular Pharmacotherapy, Jg. 10, 2024, Nr. 7, S. 571
-
The impact of Twitter/X promotion on visibility of research articles : Results of the #TweetTheJournal studyIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 50, 2024, 101328DOI (Open Access)
-
The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathologyIn: Cardiovascular Research, Jg. 120, 2024, Nr. 5, S. 506 – 518DOI, Online Volltext (Open Access)
-
The thrombin receptor PAR4 supports visceral adipose tissue inflammationIn: Naunyn-Schmiedeberg's Archives of Pharmacology, 2024DOI (Open Access)
-
Update on antithrombotic therapy and body mass : A clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on ThrombosisIn: European Heart Journal - Cardiovascular Pharmacotherapy, Jg. 10, 2024, Nr. 7, S. 614 – 645DOI (Open Access)
-
Adiposity-associated atrial fibrillation : Molecular determinants, mechanisms, and clinical significanceIn: Cardiovascular Research, Jg. 119, 2023, Nr. 3, S. 614 – 630DOI (Open Access)
-
Characterization of temporal electrical activity patterns for detection of critical isthmus regions of recurrent atypical atrial flutterIn: Clinical Cardiology, Jg. 46, 2023, Nr. 5, S. 574 – 583DOI, Online Volltext (Open Access)
-
Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activationIn: The Journal of Clinical Investigation (JCI), Jg. 133, 2023, Nr. 19, e167517DOI (Open Access)
-
Determinants and therapeutic potential of calcium handling abnormalities in atrial fibrillation : what can we learn from computer models?In: Journal of Physiology, Jg. 601, 2023, Nr. 13, Special Issue: Cell diversity and signalling in the cardiovascular system, S. 2545 – 2546DOI (Open Access)
-
Diversity of cells and signals in the cardiovascular systemIn: Journal of Physiology, Jg. 601, 2023, Nr. 13: Special Issue: Cell diversity and signalling in the cardiovascular system, S. 2547 – 2592DOI (Open Access)
-
Downregulation of FKBP5 Promotes Atrial ArrhythmogenesisIn: Circulation Research, Jg. 133, 2023, Nr. 1, S. e1 – e16DOI (Open Access)
-
Dual effects of the small-conductance Ca²⁺-activated K⁺ current on human atrial electrophysiology and Ca²⁺-driven arrhythmogenesis : An in silico studyIn: American Journal of Physiology: Heart and Circulatory Physiology, Jg. 325, 2023, Nr. 4, S. H896 – H908DOI (Open Access)
-
Enhanced Ca₂₊-Dependent SK-Channel Gating and Membrane Trafficking in Human Atrial FibrillationIn: Circulation Research, Jg. 132, 2023, Nr. 9, S. E116 – E133DOI (Open Access)
-
In silico analysis of the dynamic regulation of cardiac electrophysiology by Kv11.1 ion-channel traffickingIn: Journal of Physiology, Jg. 601, 2023, Nr. 13, Special Issue: Cell diversity and signalling in the cardiovascular system, S. 2711 – 2731DOI (Open Access)
-
Inflammatory signalling in atrial cardiomyocytes : A novel unifying principle in atrial fibrillation pathophysiologyIn: Nature Reviews Cardiology, Jg. 20, 2023, Nr. 3, S. 145 – 167
-
Integrative human atrial modelling unravels interactive protein kinase A and Ca²⁺/calmodulin-dependent protein kinase II signalling as key determinants of atrial arrhythmogenesisIn: Cardiovascular Research, Jg. 119, 2023, Nr. 13, S. 2294 – 2311DOI (Open Access)
-
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic ConditioningIn: Pharmacological Reviews, Jg. 75, 2023, Nr. 1, S. 159 – 216DOI (Open Access)
-
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022In: European Heart Journal - Cardiovascular Pharmacotherapy, Jg. 9, 2023, Nr. 4, S. 353 – 370DOI, Online Volltext (Open Access)
-
PET/CT-identified atrial hypermetabolism is an index of atrial inflammation in patients with atrial fibrillationIn: Journal of Nuclear Cardiology, Jg. 30, 2023, Nr. 5, S. 1761 – 1772.
-
PPP1R12C Promotes Atrial Hypocontractility in Atrial FibrillationIn: Circulation Research, Jg. 133, 2023, Nr. 9, S. 758 – 771
-
Phosphodiesterase 8 governs cAMP/PKA-dependent reduction of L-type calcium current in human atrial fibrillation : a novel arrhythmogenic mechanismIn: European Heart Journal, Jg. 44, 2023, Nr. 27, S. 2483 – 2494DOI (Open Access)
-
Recent Advances in Antiarrhythmic Drug TherapyIn: Drugs, Jg. 83, 2023, Nr. 13, S. 1147 – 1160DOI (Open Access)
-
Searching for atrial fibrillation : looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper’In: EP Europace, Jg. 25, 2023, Nr. 1, S. 185 – 198DOI (Open Access)
-
The European Society of Cardiology working group on cardiovascular pharmacotherapyIn: European Heart Journal, Jg. 44, 2023, Nr. 42, S. 4400 – 4402DOI (Open Access)
-
Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?In: European Heart Journal - Cardiovascular Pharmacotherapy, Jg. 9, 2023, Nr. 6, S. 570 – 582DOI, Online Volltext (Open Access)
-
Visualization of fibroblast activation using ⁶⁸Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablationIn: Journal of Nuclear Cardiology, Jg. 30, 2023, Nr. 5, S. 2018 – 2028DOI (Open Access)
-
Vorhofflimmern nach herzchirurgischen Eingriffen : Zusammenfassung der einer MetaanalyseIn: Zeitschrift für Herz-, Thorax- und Gefäßchirurgie (ZHTG), Jg. 37, 2023, Nr. 2, S. 106 – 112
-
Atrial disease and heart failure : The common soil hypothesis proposed by the Heart Failure Association of the European Society of CardiologyIn: European Heart Journal, Jg. 43, 2022, Nr. 9, S. 863 – 867DOI, Online Volltext (Open Access)
-
Common disease-promoting signalling pathways in heart failure and atrial fibrillation : putative underlying mechanisms and potential therapeutic consequencesIn: Cardiovascular Research, Jg. 118, 2022, Nr. 11, S. 2397 – 2399DOI (Open Access)
-
Conditional immortalization of human atrial myocytes for the generation of in vitro models of atrial fibrillationIn: Nature Biomedical Engineering, Jg. 6, 2022, Nr. 4, S. 389 – 402DOI, Online Volltext (Open Access)
-
Emerging Antiarrhythmic Drugs for Atrial FibrillationIn: International Journal of Molecular Sciences (IJMS), Jg. 23, 2022, Nr. 8, 4096DOI, Online Volltext (Open Access)
-
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease : A review by the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyIn: European Heart Journal - Cardiovascular Pharmacotherapy, Jg. 8, 2022, Nr. 4, S. 406 – 419DOI (Open Access)
-
Genetic inhibition of nuclear factor of activated T-cell c2 prevents atrial fibrillation in CREM transgenic miceIn: Cardiovascular Research, Jg. 118, 2022, Nr. 13, S. 2805 – 2818DOI, Online Volltext (Open Access)
-
Geschlechtsspezifische Unterschiede in der PharmakologieIn: Aktuelle Kardiologie, Jg. 11, 2022, Nr. 1, S. 62 – 66
-
Gut microbiota, dysbiosis and atrial fibrillation : Arrhythmogenic mechanisms and potential clinical implicationsIn: Cardiovascular Research, Jg. 118, 2022, Nr. 11, S. 2415 – 2427DOI, Online Volltext (Open Access)
-
In-depth characterization of a mouse model of postoperative atrial fibrillationIn: The Journal of Cardiovascular Aging, Jg. 2, 2022, Nr. 4, 40DOI (Open Access)
-
Molecular determinants and therapeutic potential of focal ectopic activity : more than meets the ItiIn: European Heart Journal, 2022, ehac357
-
Recent highlights on acute myocardial infarction and takotsubo syndrome from the International Journal of Cardiology : Heart & VasculatureIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 43, 2022, 101155DOI (Open Access)
-
Recent highlights on thrombosis and hemostasis from the International Journal of Cardiology : Heart & VasculatureIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 43, 2022, 101145DOI (Open Access)
-
Researchers in cardiology : Why and how to get on Twitter?In: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 40, 2022, 101010DOI (Open Access)
-
Role of catheter location on local impedance measurements and clinical outcome with the new direct sense technology in cardiac ablation proceduresIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 42, 2022, 101109DOI (Open Access)
-
Rotors anchored by refractory islands drive torsades de pointes in an experimental model of electrical stormIn: Heart Rhythm, Jg. 19, 2022, Nr. 2
-
Sleep apnea and atrial fibrillation : challenges in clinical and translational researchIn: Expert Review of Cardiovascular Therapy, Jg. 20, 2022, Nr. 2, S. 101 – 109DOI (Open Access)
-
Sleep-Disordered Breathing and Cardiac Arrhythmias in Adults: Mechanistic Insights and Clinical Implications : A Scientific Statement From the American Heart AssociationIn: Circulation, Jg. 146, 2022, Nr. 9, S. E119 – E136DOI, Online Volltext (Open Access)
-
TGF-β1-induced endothelial-mesenchymal transition : a potential contributor to fibrotic remodeling in atrial fibrillation?In: The Journal of Clinical Investigation (JCI), Jg. 132, 2022, Nr. 13, e161070DOI (Open Access)
-
The impact of an atrial septal defect on the progression of atrial tachypacing-induced atrial fibrillation in a Danish Landrace pig : A case reportIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 40, 2022, 101054DOI (Open Access)
-
Angiotensin receptor-neprilysin inhibitor (ARNI) and cardiac arrhythmiasIn: International Journal of Molecular Sciences (IJMS), Jg. 22, 2021, Nr. 16, 8994DOI (Open Access)
-
Atrial fibrillation in a dish : insights into atrial arrhythmogenesis from induced pluripotent stem cell-derived cardiomyocytesIn: Cardiovascular Research, Jg. 116, 2021, Nr. 6, S. 1089 – 1091DOI (Open Access)
-
Atrial-Specific LKB1 Knockdown Represents a Novel Mouse Model of Atrial Cardiomyopathy With Spontaneous Atrial FibrillationIn: Circulation, Jg. 144, 2021, Nr. 11, S. 909 – 912DOI (Open Access)
-
Cellular mechanisms of the anti-arrhythmic effect of cardiac pde2 overexpressionIn: International Journal of Molecular Sciences (IJMS), Jg. 22, 2021, Nr. 9, S. 4816DOI (Open Access)
-
Challenges and opportunities in improving the management of atrial fibrillation : recent research advances and their clinical translationIn: Cardiovascular Research, Jg. 117, 2021, Nr. 7, S. 1609 – 1611DOI (Open Access)
-
Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial FibrillationIn: Circulation Research, Jg. 129, 2021, Nr. 8, S. 804 – 820DOI (Open Access)
-
Direct oral anticoagulation and severe obesity – One size fits all?In: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 37, 2021, 100923DOI (Open Access)
-
Does gut microbiota affect atrial rhythm? : Causalities and speculationsIn: European Heart Journal, Jg. 42, 2021, Nr. 35, S. 3521 – 3525DOI, Online Volltext (Open Access)
-
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation : The 7th AFNET/EHRA Consensus ConferenceIn: EP Europace, Jg. 23, 2021, Nr. 3, S. 329 – 344DOI (Open Access)
-
ESC working group on cardiac cellular electrophysiology position paper : relevance, opportunities, and limitations of experimental models for cardiac electrophysiology researchIn: EP Europace, Jg. 23, 2021, Nr. 11, S. 1795 – 1814DOI (Open Access)
-
Edward Carmeliet (1930-2021)-channelling scientific curiosity : a tribute from the ESC Working Group on Cardiac Cellular Electrophysiology†In: Cardiovascular Research, Jg. 117, 2021, Nr. 14, S. e171 – e173DOI, Online Volltext (Open Access)
-
Inositol Trisphosphate Receptors and Nuclear Calcium in Atrial FibrillationIn: Circulation Research, Jg. 128, 2021, Nr. 5, S. 619 – 635DOI (Open Access)
-
Kv1.1 potassium channel subunit deficiency alters ventricular arrhythmia susceptibility, contractility, and repolarizationIn: Physiological Reports, Jg. 9, 2021, Nr. 1, e14702DOI (Open Access)
-
Mapping genetic changes in the cAMP-signaling cascade in human atriaIn: Journal of Molecular and Cellular Cardiology, Jg. 155, 2021, S. 10 – 20DOI, Online Volltext (Open Access)
-
NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmiasIn: Cardiovascular Research, Jg. 117, 2021, Nr. 7, S. 1746 – 1759DOI, Online Volltext (Open Access)
-
Pericardial adipose tissue : An emerging biomarker of atrial fibrillation?In: International Journal of Cardiology, Jg. 331, 2021, S. 122 – 123
-
Postoperative Atrial Fibrillation : Features, Mechanisms, and Clinical ManagementIn: Cardiac Electrophysiology Clinics, Jg. 13, 2021, Nr. 1, S. 123 – 132
-
SPEG: A key regulator of cardiac calcium homeostasisIn: Cardiovascular Research, Jg. 117, 2021, Nr. 10, S. 2175 – 2185DOI (Open Access)
-
Surgery-related cardiac stress : A susceptibility test of late atrial fibrillation recurrence?In: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 32, 2021, S. 100693DOI (Open Access)
-
The crosstalk between cardiomyocyte calcium and inflammasome signaling pathways in atrial fibrillationIn: Pflügers Archiv: European Journal of Physiology, Jg. 473, 2021, S. 389 – 405DOI (Open Access)
-
The impact of Twitter promotion on future citation rates : The #TweetTheJournal studyIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 33, 2021, 100776DOI (Open Access)
-
The virtual patient : Estimating the health utility of aspirin in simulated populationsIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 36, 2021, 100857DOI (Open Access)
-
Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving itIn: Cardiovascular Research, Jg. 117, 2021, Nr. 7, S. 1616 – 1631DOI (Open Access)
-
Acute effects of alcohol on cardiac electrophysiology and arrhythmogenesis : Insights from multiscale in silico analysesIn: Journal of Molecular and Cellular Cardiology, Jg. 146, 2020, S. 69 – 83DOI (Open Access)
-
Altered calcium handling produces reentry-promoting action potential alternans in atrial fibrillation-remodeled heartsIn: JCI Insight, Jg. 5, 2020, Nr. 8, e133754DOI (Open Access)
-
Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation : Rationale and design of the PROMISE-AF phase II studyIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 29, 2020, S. 100573DOI (Open Access)
-
Atrial Myocyte NLRP3/CaMKII Nexus Forms a Substrate for Postoperative Atrial FibrillationIn: Circulation Research, Jg. 127, 2020, Nr. 8, S. 1036 – 1055DOI, Online Volltext (Open Access)
-
Berücksichtigung QTc-verlängerndes Potenzial : „Vor Einleitung einer Therapie mit Antibiotika, Antipsychotika, Antiarrhythmika soll die Gefahr einer klinisch relevanten QTc-Verlängerung geprüft werden“In: Der Kardiologe, Jg. 14, 2020, S. 32 – 34
-
Breaking bad : Higher risk of osteoporosis with vitamin K antagonists compared to direct oral anticoagulants in patients with atrial fibrillationIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 27, 2020, S. 100487DOI (Open Access)
-
COVID-19 associated atrial fibrillation : Incidence, putative mechanisms and potential clinical implicationsIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 30, 2020, S. 100631DOI (Open Access)
-
CaMKII activity contributes to homeometric autoregulation of the heart : A novel mechanism for the Anrep effectIn: Journal of Physiology, 2020DOI, Online Volltext (Open Access)
-
Cardiomyocyte calcium handling in health and disease : Insights from in vitro and in silico studiesIn: Progress in Biophysics and Molecular Biology, Jg. 157, 2020, S. 54 – 75DOI (Open Access)
-
Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effectsIn: Nature Communications, Jg. 11, 2020, Nr. 1, S. 1733DOI (Open Access)
-
Left-ventricular innervation assessed by ¹²³I-SPECT/CT is associated with cardiac events in inherited arrhythmia syndromesIn: International Journal of Cardiology, 2020
-
Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial FibrillationIn: Circulation, Jg. 142, 2020, Nr. 12, S. 1159 – 1172DOI (Open Access)
-
Management of patients with newly-diagnosed atrial fibrillation : Insights from the BALKAN-AF surveyIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 26, 2020, S. 100461DOI (Open Access)
-
Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy : A Translational PerspectiveIn: Circulation Research, Jg. 127, 2020, Nr. 1, S. 51 – 72DOI (Open Access)
-
On-demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultationIn: Clinical Cardiology, Jg. 43, 2020, Nr. 11, S. 1232 – 1239DOI (Open Access)
-
Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosisIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 28, 2020, S. 100535DOI (Open Access)
-
Sleep apnea and atrial fibrillation : Update 2020In: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 31, 2020, S. 100681DOI (Open Access)
-
Smart device-based detection of atrial fibrillation: Opportunities and challenges in the emerging world of digital healthIn: International Journal of Cardiology, Jg. 302, 2020, S. 108 – 109
-
The role of amiodarone in contemporary management of complex cardiac arrhythmiasIn: Pharmacological Research, Jg. 151, 2020, S. 104521
-
Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heartIn: Basic Research in Cardiology, Jg. 115, 2020, Nr. 2, S. 10DOI, Online Volltext (Open Access)
-
Ablation of the calpain-targeted site in cardiac myosin binding protein-C is cardioprotective during ischemia-reperfusion injuryIn: Journal of Molecular and Cellular Cardiology, Jg. 129, 2019, S. 236 – 246DOI (Open Access)
-
Bayesian network analyses in atrial fibrillation – A path to better therapies?In: International Journal of Cardiology (IJC) Heart & Vasculature, 2019DOI (Open Access)
-
Computational modeling: What does it tell us about atrial fibrillation therapy?In: International Journal of Cardiology, Jg. 287, 2019, S. 155 – 161DOI, Online Volltext (Open Access)
-
DPP10 is a new regulator of Nav1.5 channels in human heartIn: International Journal of Cardiology, Jg. 284, 2019, S. 68 – 73
-
Double Jeopardy: Will the new trials tell us how to manage patients with atrial fibrillation and coronary artery disease?In: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 23, 2019, S. 100369DOI (Open Access)
-
EHRA White Paper : Knowledge Gaps in Arrhythmia Management-Status 2019In: EP Europace, Jg. 21, 2019, Nr. 7, S. 993 – 994DOI, Online Volltext (Open Access)
-
Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial FibrillationIn: Circulation, Jg. 140, 2019, Nr. 8, S. 681 – 693DOI (Open Access)
-
Maastricht antiarrhythmic drug evaluator (MANTA) : A computational tool for better understanding of antiarrhythmic drugsIn: Pharmacological Research, Jg. 148, 2019DOI (Open Access)
-
Nightly sleep apnea severity in patients with atrial fibrillation : Potential applications of long-term sleep apnea monitoringIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 24, 2019, S. 100424DOI (Open Access)
-
Postoperative atrial fibrillation : mechanisms, manifestations and managementIn: Nature Reviews Cardiology, Jg. 16, 2019, Nr. 7, S. 417 – 436
-
Role of autonomic nervous system in atrial fibrillationIn: International Journal of Cardiology, Jg. 287, 2019, S. 181 – 188
-
Role of inflammatory signaling in atrial fibrillationIn: International Journal of Cardiology, Jg. 287, 2019, S. 195 – 200DOI, Online Volltext (Open Access)
-
Straight to the heart : Pleiotropic antiarrhythmic actions of oral anticoagulantsIn: Pharmacological Research, Jg. 145, 2019, S. 104257DOI, Online Volltext (Open Access)
-
Use of pulsed electron avalanche knife (PEAK) PlasmaBlade™ in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillatorIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 24, 2019, S. 100390DOI (Open Access)
-
Age-dependent increase in c-Jun N-terminal kinase-2 activity : Does this help to understand Ca2+ -calmodulin-dependent protein-kinase II-mediated atrial arrhythmogenesis in human atrial fibrillation?In: Cardiovascular Research, Jg. 114, 2018, Nr. 5, S. 641 – 642DOI (Open Access)
-
Antiarrhythmic drugs for atrial fibrillation : Imminent impulses are emergingIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 21, 2018, S. 11 – 15DOI (Open Access)
-
Calcium-dependent regulation of potassium channels in cardiac electrophysiology : A computational studyIn: Biophysical Journal, Jg. 114, 2018, Nr. 3, Supplement 1, S. 473aDOI (Open Access)
-
Can cystatin C-based estimated glomerular filtration rate help to guide individualized risk factor modification programs?In: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 19, 2018, S. 100 – 101DOI (Open Access)
-
Cardiomyocyte inflammasome signaling in cardiomyopathies and atrial fibrillation : Mechanisms and potential therapeutic implicationsIn: Frontiers in Physiology, Jg. 9, 2018, S. 1115DOI (Open Access)
-
Conventional Troponin-I versus high-sensitivity troponin-T : Performance and incremental prognostic value in non-ST-elevation acute myocardial infarction patients with negative CK-MB based on a real-world multicenter cohortIn: International Journal of Cardiology (IJC) Heart & Vasculature, Jg. 20, 2018, S. 38 – 39DOI (Open Access)
-
Ectopic expression of S28A-mutated Histone H3 modulates longevity, stress resistance and cardiac function in DrosophilaIn: Scientific Reports, Jg. 8, 2018, Nr. 1, S. 2940DOI (Open Access)
-
Electrical storm : Mechanistic and therapeutic considerations to avoid death in the survivorsIn: Journal of Thoracic Disease, Jg. 10, 2018, Nr. Suppl. 33, S. S4053 – S4056DOI (Open Access)
-
Electrocardiographic characteristics associated with atrial fibrillation – What do they tell us?In: International Journal of Cardiology, Jg. 266, 2018, S. 143 – 144
-
Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillationIn: Circulation, Jg. 138, 2018, Nr. 20, S. 2227 – 2242DOI, Online Volltext (Open Access)
-
Identification of optimal reference genes for transcriptomic analyses in normal and diseased human heartIn: Cardiovascular Research, Jg. 114, 2018, Nr. 2, S. 247 – 258DOI (Open Access)
-
In silico assessment of atrial fibrillation-selectivity of ikur inhibitors : Role of variability in disease-associated remodelingIn: Biophysical Journal, Jg. 114, 2018, Nr. 3, Suppl. 1, S. 473a – 474aDOI (Open Access)
-
Integrating new approaches to atrial fibrillation management : The 6th AFNET/EHRA Consensus ConferenceIn: EP Europace, Jg. 20, 2018, Nr. 3, S. 395 – 407DOI (Open Access)
-
Ion channels as part of macromolecular multiprotein complexes : Clinical significanceIn: Herzschrittmachertherapie und Elektrophysiologie, Jg. 29, 2018, Nr. 1, S. 30 – 35DOI (Open Access)
-
Mouse Models of Cardiac ArrhythmiasIn: Circulation Research, Jg. 123, 2018, Nr. 3, S. 332 – 334DOI, Online Volltext (Open Access)
-
Muscarinic type-1 receptors contribute to IK,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillationIn: International Journal of Cardiology, Jg. 255, 2018, S. 61 – 68DOI, Online Volltext (Open Access)
-
Non-ion channel therapeutics for heart failure and atrial fibrillation : Are CaMKII inhibitors ready for clinical use?In: Journal of Molecular and Cellular Cardiology, Jg. 121, 2018, S. 300 – 303DOI, Online Volltext (Open Access)
-
Novel role of the protein phosphatase 1 regulatory subunit PPP1R3A in atrial fibrillationIn: Journal of Molecular and Cellular Cardiology, Jg. 124, 2018, S. 108
-
Profibrotic, electrical, and calcium-handling remodeling of the atria in heart failure patients with and without atrial fibrillationIn: Frontiers in Physiology, Jg. 9, 2018, S. 1383DOI (Open Access)
-
Regulation of heterotrimeric G-protein signaling by NDPK/NME proteins and caveolins : an updateIn: Laboratory Investigation, Jg. 98, 2018, Nr. 2, S. 190 – 197DOI (Open Access)
-
Resveratrol : an effective pharmacological agent to prevent inflammation-induced atrial fibrillation?In: Naunyn-Schmiedeberg's Archives of Pharmacology, Jg. 391, 2018, Nr. 11, S. 1163 – 1167DOI (Open Access)
-
Sex-specific density of ventricular SK currents : is this a general feature of SK channel function?In: Journal of Physiology, Jg. 596, 2018, Nr. 18, S. 4287 – 4288DOI, Online Volltext (Open Access)
-
Switching off the jitters : Dabigatran as a candidate approach to halt atrial fibrillation?In: International Journal of Cardiology, Jg. 271, 2018, S. 254 – 255
-
The not-so-sweet problem of hearts aflutter : Dissecting stroke risk in atrial fibrillation with concomitant diabetesIn: International Journal of Cardiology, Jg. 268, 2018, S. 153 – 154
-
Translational challenges in atrial fibrillationIn: Circulation Research, Jg. 122, 2018, Nr. 5, S. 752 – 773DOI (Open Access)
-
Calcium Signaling and Cardiac ArrhythmiasIn: Circulation Research, Jg. 120, 2017, Nr. 12, S. 1969 – 1993DOI, Online Volltext (Open Access)
-
Calcium-mediated cellular triggered activity in atrial fibrillationIn: Journal of Physiology, Jg. 595, 2017, Nr. 12, S. 4001 – 4008
-
Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activityIn: Naunyn-Schmiedeberg's Archives of Pharmacology, Jg. 390, 2017, Nr. 8, S. 857 – 862
-
Controversies about Atrial Fibrillation Mechanisms : Aiming for Order in Chaos and Whether it MattersIn: Circulation Research, Jg. 120, 2017, Nr. 9, S. 1396 – 1398DOI (Open Access)
-
Differential regulation of protein phosphatase 1 (PP1) isoforms in human heart failure and atrial fibrillationIn: Basic Research in Cardiology, Jg. 112, 2017, Nr. 4
-
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies : definition, characterization, and clinical implicationIn: Heart Rhythm, Jg. 14, 2017, Nr. 1, S. e3 – e40DOI, Online Volltext (Open Access)
-
Enhanced Activation of Inflammasome Promotes Atrial FibrillationIn: Journal of Molecular and Cellular Cardiology, Jg. 112, 2017, S. 147
-
Erratum to: "Revealing kinetics and state-dependent binding properties of IKur-targeting drugs that maximize atrial fibrillation selectivity"In: Chaos, Jg. 27, 2017, Nr. 10, 109902DOI (Open Access)
-
Erratum to: Differential regulation of protein phosphatase 1 (PP1) isoforms in human heart failure and atrial fibrillationIn: Basic Research in Cardiology, Jg. 112, 2017, Nr. 5
-
In silico assessment of efficacy and safety of Ikur inhibitors in chronic atrial fibrillation : Role of kinetics and state-dependence of drug bindingIn: Frontiers in Pharmacology, Jg. 8, 2017, Nr. NOV, S. 799DOI (Open Access)
-
Inhibition of small-conductance Ca²⁺-Activated K⁺ channels : The long-Awaited breakthrough for antiarrhythmic drug therapy of atrial fibrillation?In: Circulation: Arrhythmia and Electrophysiology, Jg. 10, 2017, Nr. 10, S. e005776
-
Inverse remodelling of K2P 3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation : Implications for patient-specific antiarrhythmic drug therapyIn: European Heart Journal, Jg. 38, 2017, Nr. 22, S. 1764 – 1774
-
Investigational antiarrhythmic agents : promising drugs in early clinical developmentIn: Expert Opinion on Investigational Drugs, Jg. 26, 2017, Nr. 8, S. 897 – 907DOI, Online Volltext (Open Access)
-
JAK-STAT signalling and the atrial fibrillation promoting fibrotic substrateIn: Cardiovascular Research, Jg. 113, 2017, Nr. 3, S. 310 – 320
-
Late-breaking trials : Atrial fibrillationIn: Dialogues in Cardiovascular Medicine, Jg. 22, 2017, Nr. 3, S. 42 – 43
-
Nucleoside Diphosphate Kinase-C Suppresses cAMP Formation in Human Heart FailureIn: Circulation, Jg. 135, 2017, Nr. 9, S. 881 – 897DOI (Open Access)
-
Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeuticsIn: Journal of Physiology, Jg. 595, 2017, Nr. 7, S. 2229 – 2252DOI (Open Access)
-
Response to: “The emerging role of hybrid ablation for ablation” by Spartialis M. et al.In: International Journal of Cardiology, Jg. 249, 2017, S. 258
-
Revealing kinetics and state-dependent binding properties of IKur-targeting drugs that maximize atrial fibrillation selectivityIn: Chaos, Jg. 27, 2017, Nr. 9, 093918DOI (Open Access)
-
Serine/Threonine Phosphatases in Atrial FibrillationIn: Journal of Molecular and Cellular Cardiology, Jg. 103, 2017, S. 110 – 120DOI, Online Volltext (Open Access)
-
The inward rectifier current inhibitor PA-6 terminates atrial fibrillation and does not cause ventricular arrhythmias in goat and dog modelsIn: British Journal of Pharmacology (BJP), Jg. 174, 2017, Nr. 15, S. 2576 – 2590DOI (Open Access)
-
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSIn: European Heart Journal, Jg. 37, 2016, Nr. 38, S. 2893 – 2962
-
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSIn: European Journal of Cardio-Thoracic Surgery, Jg. 50, 2016, Nr. 5, S. e1 – e88
-
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSIn: EP Europace, Jg. 18, 2016, Nr. 11, S. 1609 – 1678
-
A roadmap to improve the quality of atrial fibrillation managementconference : proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensusIn: EP Europace, Jg. 18, 2016, Nr. 1, S. 37 – 50DOI (Open Access)
-
An update on atrial fibrillation in 2014 : From pathophysiology to treatmentIn: International Journal of Cardiology, Jg. 203, 2016, S. 22 – 29
-
Atrial-Selective Potassium Channel BlockersIn: Cardiac Electrophysiology Clinics, Jg. 8, 2016, Nr. 2, S. 411 – 421
-
Challenges to the translation of basic science findings to atrial fibrillation therapiesIn: Future Cardiology, Jg. 12, 2016, Nr. 3, S. 251 – 254
-
Computational Analysis of Heart-Failure-Related Remodeling of Cytosolic and Nuclear Calcium Handling in the Canine Atrial CardiomyocyteIn: Biophysical Journal, Jg. 110, 2016, Nr. 3, Suppl.1, S. 435aDOI (Open Access)
-
Computational models of atrial cellular electrophysiology and calcium handling, and their role in atrial fibrillationIn: Journal of Physiology, Jg. 594, 2016, Nr. 3, S. 537 – 553
-
Current controversies in determining the main mechanisms of atrial fibrillationIn: Journal of Internal Medicine, Jg. 279, 2016, Nr. 5, S. 428 – 438
-
Deciphering the fundamental mechanisms of atrial fibrillation : a quest for over a centuryIn: Cardiovascular Research, Jg. 109, 2016, Nr. 4, S. 465 – 466
-
Differences in Left Versus Right Ventricular Electrophysiological Properties in Cardiac Dysfunction and ArrhythmogenesisIn: Arrhythmia & Electrophysiology Review, Jg. 5, 2016, Nr. 1, S. 14 – 19DOI (Open Access)
-
Dysfunction of the β2-spectrin-based pathway in human heart failureIn: American Journal of Physiology: Heart and Circulatory Physiology, Jg. 310, 2016, Nr. 11, S. H1583 – H1591DOI (Open Access)
-
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: : definition, characterisation, and clinical implicationIn: Journal of Arrhythmia, Jg. 32, 2016, Nr. 4, S. 247 – 278DOI (Open Access)
-
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies : definition, characterization, and clinical implicationIn: EP Europace, Jg. 18, 2016, Nr. 10, S. 1455 – 1490
-
Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillationIn: Nature Reviews Cardiology, Jg. 13, 2016, Nr. 10, S. 575 – 590
-
PITX2 : a master regulator of cardiac channelopathy in atrial fibrillation?In: Cardiovascular Research, Jg. 109, 2016, Nr. 3, S. 345 – 347
-
Regulating the regulator : Insights into the cardiac protein phosphatase 1 interactomeIn: Journal of Molecular and Cellular Cardiology, Jg. 101, 2016, S. 165 – 172DOI, Online Volltext (Open Access)
-
Response to Letter Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation"In: Circulation, Jg. 133, 2016, Nr. 11, S. e440 – 441DOI, Online Volltext (Open Access)
-
S-glutathiolation impairs phosphoregulation and function of cardiac myosin-binding protein C in human heart failureIn: The FASEB Journal, Jg. 30, 2016, Nr. 5, S. 1849 – 1864DOI, Online Volltext (Open Access)
-
The combined effects of ranolazine and dronedarone on human atrial and ventricular electrophysiologyIn: Journal of Molecular and Cellular Cardiology, Jg. 94, 2016, S. 95 – 106
-
The multiple proarrhythmic roles of cardiac calcium-handling abnormalities : triggered activity, conduction abnormalities, beat-to-beat variability, and adverse remodellingIn: EP Europace, Jg. 18, 2016, Nr. 10, S. 1452 – 1454
-
The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation : a critical analysisIn: Cardiovascular Research, Jg. 109, 2016, Nr. 4, S. 467 – 479
-
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death : The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the EuropeIn: EP Europace, Jg. 17, 2015, Nr. 11, S. 1601 – 1687
-
Alterations in the interactome of serine/threonine protein phosphatase type-1 in atrial fibrillation patientsIn: Journal of the American College of Cardiology (JACC), Jg. 65, 2015, Nr. 2, S. 163 – 173DOI (Open Access)
-
Altered atrial metabolism : an underappreciated contributor to the initiation and progression of atrial fibrillationIn: Journal of the American Heart Association, Jg. 4, 2015, Nr. 3, S. e001808DOI (Open Access)
-
Application of the RIMARC algorithm to a large data set of action potentials and clinical parameters for risk prediction of atrial fibrillationIn: Medical and Biological Engineering and Computing, Jg. 53, 2015, Nr. 3, S. 263 – 273DOI (Open Access)
-
Atrial Fibrillation Activates AMP-Dependent Protein Kinase and its Regulation of Cellular Calcium Handling : Potential Role in Metabolic Adaptation and Prevention of ProgressionIn: Journal of the American College of Cardiology (JACC), Jg. 66, 2015, Nr. 1, S. 47 – 58DOI (Open Access)
-
Calcium Handling Abnormalities as a Target for Atrial Fibrillation Therapeutics : How Close to Clinical Implementation?In: Journal of Cardiovascular Pharmacology, Jg. 66, 2015, Nr. 6, S. 515 – 522
-
Counteracting Protein Kinase Activity in the Heart : The Multiple Roles of Protein PhosphatasesIn: Frontiers in Pharmacology, Jg. 6, 2015, S. 270DOI (Open Access)
-
Dysfunction in the βII spectrin-dependent cytoskeleton underlies human arrhythmiaIn: Circulation, Jg. 131, 2015, Nr. 8, S. 695 – 708DOI (Open Access)
-
Expression and function of Kv1.1 potassium channels in human atria from patients with atrial fibrillationIn: Basic Research in Cardiology, Jg. 110, 2015, Nr. 5, S. 47DOI, Online Volltext (Open Access)
-
Fibroblast inward-rectifier potassium current upregulation in profibrillatory atrial RemodelingIn: Circulation Research, Jg. 116, 2015, Nr. 5, S. 836 – 845DOI (Open Access)
-
Identification of microRNA-mRNA dysregulations in paroxysmal atrial fibrillationIn: International Journal of Cardiology, Jg. 184, 2015, S. 190 – 197DOI, Online Volltext (Open Access)
-
Innovative therapeutics for atrial fibrillation : Imminent breakthroughs or much ado about nothing?In: Journal of Cardiovascular Pharmacology, Jg. 66, 2015, Nr. 5, S. 409 – 411
-
Irregular rhythm and atrial metabolism are key for the evolution of proarrhythmic atrial remodeling in atrial fibrillationIn: Basic Research in Cardiology, Jg. 110, 2015, S. 41
-
Loss of Cardiomyocyte Integrin-Linked Kinase Produces an Arrhythmogenic Cardiomyopathy in MiceIn: Circulation: Arrhythmia and Electrophysiology, Jg. 8, 2015, Nr. 4, S. 921 – 932DOI (Open Access)
-
Methods for isolating atrial cells from large mammals and humansIn: Journal of Molecular and Cellular Cardiology, Jg. 86, 2015, S. 187 – 198DOI (Open Access)
-
New antiarrhythmic targets in atrial fibrillationIn: Future Cardiology, Jg. 11, 2015, Nr. 6, S. 645 – 654
-
Nucleoside Diphosphate Kinase B–Activated Intermediate Conductance Potassium Channels Are Critical for Neointima Formation in Mouse Carotid ArteriesIn: Arteriosclerosis, Thrombosis, and Vascular Biology, Jg. 35, 2015, Nr. 8, S. 1852 – 1861DOI (Open Access)
-
The European Network for Translational Research in Atrial Fibrillation (EUTRAF) : Objectives and initial resultsIn: EP Europace, Jg. 17, 2015, Nr. 10, S. 1457 – 1466DOI (Open Access)
-
Tools to Keep the Clock Ticking : Molecular approaches to treat Sinus Node DysfunctionIn: Cardiology, Jg. 132, 2015, Nr. 1, S. 45 – 48
-
Upregulation of K(2P)3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial FibrillationIn: Circulation, Jg. 132, 2015, Nr. 2, S. 82 – 92DOI (Open Access)
-
2014 ESC/EACTS Guidelines on myocardial revascularization : the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contributionIn: European Journal of Cardio-Thoracic Surgery, Jg. 46, 2014, Nr. 4, S. 517 – 592
-
Calcium dysregulation in atrial fibrillation : the role of CaMKIIIn: Frontiers in Pharmacology, Jg. 5, 2014, S. 30DOI (Open Access)
-
Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophyIn: Circulation, Jg. 130, 2014, Nr. 15, S. 1262 – 1273DOI, Online Volltext (Open Access)
-
Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progressionIn: Circulation Research, Jg. 114, 2014, Nr. 9, S. 1483 – 1499
-
Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillationIn: Circulation, Jg. 129, 2014, Nr. 2, S. 145 – 156
-
Detailed characterization of microRNA changes in a canine heart failure model : Relationship to arrhythmogenic structural remodelingIn: Journal of Molecular and Cellular Cardiology, Jg. 77, 2014, S. 113 – 124
-
GW25-e5168 Impaired Post-Transcriptional Regulation of RyR2 by microRNA-106b-25 Cluster Promotes Atrial FibrillationIn: Journal of the American College of Cardiology (JACC), Jg. 64, 2014, Nr. 16 Suppl., S. C59
-
Impaired local regulation of ryanodine receptor type 2 by protein phosphatase 1 promotes atrial fibrillationIn: Cardiovascular Research, Jg. 103, 2014, Nr. 1, S. 178 – 187DOI, Online Volltext (Open Access)
-
Kardiovaskuläre Pharmakotherapie : Risiken und NebenwirkungenIn: Herz: Cardiovascular Diseases, Jg. 39, 2014, Nr. 2, S. 227 – 240
-
Loss of MicroRNA-106b-25 Cluster Promotes Atrial Fibrillation by Enhancing Ryanodine Receptor Type-2 Expression and Calcium ReleaseIn: Circulation: Arrhythmia and Electrophysiology, Jg. 7, 2014, Nr. 6, S. 1214 – 1222
-
MicroRNA regulation and cardiac calcium signaling : Role in cardiac disease and therapeutic potentialIn: Circulation Research, Jg. 114, 2014, Nr. 4, S. 689 – 705
-
Rat engineered heart tissue : a novel tool in the safety pharmacology toolkit?In: Basic Research in Cardiology, Jg. 109, 2014, Nr. 6, S. 437
-
Role of RyR2 phosphorylation in heart failure and arrhythmias : Controversies around ryanodine receptor phosphorylation in cardiac diseaseIn: Circulation Research, Jg. 114, 2014, Nr. 8, S. 1311 – 1319
-
Role of small-conductance calcium-activated potassium channels in atrial electrophysiology and fibrillation in the dogIn: Circulation, Jg. 129, 2014, Nr. 4, S. 430 – 440
-
Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse modelIn: Circulation, Jg. 129, 2014, Nr. 12, S. 1276 – 1285
-
Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytesIn: The Journal of Clinical Investigation (JCI), Jg. 124, 2014, Nr. 11, S. 4759 – 4772
-
The clinical profile and pathophysiology of atrial fibrillation : Relationships among clinical features, epidemiology, and mechanismsIn: Circulation Research, Jg. 114, 2014, Nr. 9, S. 1453 – 1468
-
Atrial fibrillation promotion by endurance exercise : demonstration and mechanistic exploration in an animal modelIn: Journal of the American College of Cardiology (JACC), Jg. 62, 2013, Nr. 1, S. 68 – 77
-
Electrical storm : recent pathophysiological insights and therapeutic consequencesIn: Basic Research in Cardiology, Jg. 108, 2013, Nr. 2, S. 336
-
Function and regulation of serine/threonine phosphatases in the healthy and diseased heartIn: Journal of Molecular and Cellular Cardiology, Jg. 64, 2013, S. 90 – 98
-
Impaired Na+-dependent regulation of acetylcholine-activated inward-rectifier K+ current modulates action potential rate dependence in patients with chronic atrial fibrillationIn: Journal of Molecular and Cellular Cardiology, Jg. 61, 2013, S. 142 – 152
-
Isolation of human atrial myocytes for simultaneous measurements of Ca2+ transients and membrane currents.In: JoVE, 2013, Nr. 77, S. e50235
-
MicroRNA29 : a mechanistic contributor and potential biomarker in atrial fibrillationIn: Circulation, Jg. 127, 2013, Nr. 14, S. 1466 – 1475
-
Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilizationIn: Journal of the American College of Cardiology (JACC), Jg. 62, 2013, Nr. 21, S. 2010 – 2019DOI (Open Access)
-
NSC23766, a widely used inhibitor of Rac1 activation, additionally Acts as a competitive antagonist at muscarinic acetylcholine receptorsIn: The Journal of Pharmacology and Experimental Therapeutics, Jg. 347, 2013, Nr. 1, S. 69 – 79
-
New directions in antiarrhythmic drug therapy for atrial fibrillationIn: Future Cardiology, Jg. 9, 2013, Nr. 1, S. 71 – 88
-
Oxidized Ca2+/Calmodulin-Dependent Protein Kinase II Triggers Atrial FibrillationIn: Circulation, Jg. 128, 2013, Nr. 16, S. 1748 – 1757
-
Personalized management of atrial fibrillation : Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conferenceIn: EP Europace, Jg. 15, 2013, Nr. 11, S. 1540 – 1556
-
Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytesIn: Journal of the American College of Cardiology (JACC), Jg. 62, 2013, Nr. 17, S. 1596 – 1606
-
Pleiotropic actions of amiodarone : still puzzling after half a centuryIn: Naunyn-Schmiedeberg's Archives of Pharmacology, Jg. 386, 2013, Nr. 7, S. 571 – 574
-
Pleiotropic effects of antiarrhythmic agents : dronedarone in the treatment of atrial fibrillationIn: Clinical Medicine Insights: Cardiology, Jg. 7, 2013, S. 127 – 140DOI (Open Access)
-
Rhythm control of atrial fibrillation in heart failureIn: Heart Failure Clinics, Jg. 9, 2013, Nr. 4, S. 407 – 415
-
Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation : an updateIn: Vascular Health and Risk Management, Jg. 9, 2013, S. 165 – 175
-
T-type calcium current contributes to escape automaticity and governs the occurrence of lethal arrhythmias after atrioventricular block in miceIn: Circulation: Arrhythmia and Electrophysiology, Jg. 6, 2013, Nr. 4, S. 799 – 808
-
The biology of human pulmonary veins : does it help us to better understand AF pathophysiology in patients?In: Heart Rhythm, Jg. 10, 2013, Nr. 3, S. 392 – 393
-
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options : a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conferenceIn: EP Europace, Jg. 14, 2012, Nr. 1, S. 8 – 27
-
Quantification of G protein Gαs subunit splice variants in different human tissues and cells using pyrosequencingIn: Gene Expression, Jg. 12, 2004, Nr. 2, S. 69 – 81DOI (Open Access)
-
Atrial fibrillation does not equal atrial fibrillation : The important prognostic implications of new-onset atrial fibrillationIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 56, 2025, 101572DOI (Open Access)
-
Diabetes and atrial fibrillation: Causality is still a black-boxIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 58, 2025, 101669
-
Recent highlights from the International Journal of Cardiology Heart & Vasculature : Stroke prevention and rhythm control in patients with atrial fibrillationIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 61, 2025, 101816DOI (Open Access)
-
Recent highlights from the International Journal of Cardiology Heart & Vasculature : cardiometabolic diseaseIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 60, 2025, 101779DOI (Open Access)
-
Sex and atrial fibrillation-associated risk estimation and managementIn: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 423, 2025, 133000
-
The inflammatory and nutritional status in patients with dilated cardiomyopathy : Different impact for distinct phenogroups?In: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 56, 2025, 101610DOI (Open Access)
-
Inflammatory gut-heart interactions : Is there a link between inflammatory bowel disease and atrial fibrillation?In: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 55, 2024, Nr. 12, 101537DOI (Open Access)
-
Protease-activated receptor 2 at the intersection of thrombo-inflammation and beyondIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 52, 2024, 101403DOI (Open Access)
-
Recent highlights from the International Journal of Cardiology Heart & Vasculature : Basic and translational researchIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 53, 2024, 101452DOI (Open Access)
-
Recent highlights from the International Journal of Cardiology Heart & Vasculature : Transcatheter aortic valve implantationIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 55, 2024, 101518DOI (Open Access)
-
Recent highlights from the International Journal of Cardiology Heart and Vasculature : Spatiotemporal and functional immunoprofiling and its theranostic potentialIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 53, 2024, 101468DOI (Open Access)
-
Recent highlights from the International Journal of Cardiology heart & Vasculature: Comprehensive management of atrial fibrillationIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 53, 2024, 101478DOI (Open Access)
-
Spexin Hormone Signaling and Atrial Fibrillation : The Knowns and UnknownsIn: Circulation. Baltimore; New York, NY; Dallas: American Heart Association, Jg. 150, 2024, Nr. 2, S. 128 – 131
-
Towards improved detection of subclinical atrial fibrillation : Who could benefit from targeted screening?In: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 55, 2024, Nr. 12, 101550DOI (Open Access)
-
Botulinum toxin for prevention of post-operative atrial fibrillationIn: Naunyn-Schmiedeberg's Archives of Pharmacology. Berlin: Springer, Jg. 396, 2023, Nr. 3, S. 385 – 388DOI (Open Access)
-
Does weight matter in cryoballoon ablation?In: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 47, 2023, 101251DOI (Open Access)
-
Evolving insights into the pleiotropic cardioprotective mechanisms of SGLT2 inhibitorsIn: Naunyn-Schmiedeberg's Archives of Pharmacology. Berlin: Springer, Jg. 396, 2023, Nr. 4, S. 589 – 592DOI (Open Access)
-
Recent highlights from the International Journal of Cardiology Heart & Vasculature on challenges for adequate stroke prevention in patients with atrial fibrillationIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 48, 2023, 101259DOI (Open Access)
-
Recent highlights on coronary artery disease from the International Journal of Cardiology Heart & VasculatureIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 49, 2023, 101295DOI (Open Access)
-
Recent highlights on myocarditis and cardiomyopathies from the International Journal of Cardiology and International Journal of Cardiology : Heart & VasculatureIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 49, 2023, 101315DOI (Open Access)
-
Recent highlights on specific aspects of oral anticoagulation in difficult clinical scenarios from the International Journal of Cardiology Heart & VasculatureIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 48, 2023, 101260DOI (Open Access)
-
Recent highlights on the mechanistic basis of cardiovascular remodeling from the International Journal of Cardiology Heart & VasculatureIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 47, 2023, 101248DOI (Open Access)
-
Recent highlights on the prevalence and role of sleep disordered breathing in cardiovascular diseases from the International Journal of Cardiology Heart & VasculatureIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 49, 2023, 101287DOI (Open Access)
-
A Gut Feeling : Lipopolysaccharide Links Gut Dysbiosis With Inflammatory Atrial Cardiomyopathy, Obesity, and Atrial FibrillationIn: Canadian Journal of Cardiology. Amsterdam: Elsevier, Jg. 38, 2022, Nr. 12, S. 1976 – 1978DOI, Online Volltext (Open Access)
-
Assessment of atrial function by echocardiography : Can this be used to assess the arrhythmogenic atrial substrate?In: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 362, 2022, S. 190 – 191
-
Atrial fibrillation substrate development before, during and after cardiac surgery : Who is to blame for late post-operative atrial fibrillation?In: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 365, 2022, S. 44 – 46DOI, Online Volltext (Open Access)
-
Chronic total occlusion of infarct-related artery : A bystander or a risk factor of electrical storm?In: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 359, 2022, S. 36 – 37
-
Fat chance for POAF? : Pericardial adipose tissue and the arrhythmogenic substrate for postoperative atrial fibrillationIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 39, 2022, 101000DOI (Open Access)
-
Minding the gap – Heterogeneity of antithrombotic treatment preferences in complex scenarios in absence of evidence-based guidelinesIn: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 348, 2022, S. 83 – 84
-
Persisting stroke risk in patients with atrial fibrillation despite proper anticoagulation : Unmet clinical needsIn: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 368, 2022, S. 39 – 40
-
Recent highlights on myocarditis, cardiovascular complications of COVID-19, and cardiomyopathies from the International Journal of Cardiology: Heart & VasculatureIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 43, 2022, 101154DOI (Open Access)
-
Targeting the RyR2 to Prevent Atrial FibrillationIn: Circulation: Arrhythmia and Electrophysiology. Philadelphia, Pa.: NLM (Medline), Jg. 15, 2022, Nr. 10, e011514
-
The temporal context of oral anticoagulation outcome in atrial fibrillationIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, 2022, 101051DOI (Open Access)
-
A disproportional rise in the growing submission rate to International Journal of Cardiology Heart & Vasculature during the COVID‑19 pandemicIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 33, 2021, S. 100749DOI (Open Access)
-
Childhood infection and modern malnutrition : Do childhood infections create an inflammatory foundation for atherosclerosis in adult life?In: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 35, 2021, 100840DOI (Open Access)
-
Gut-microbiota derived TMAO : A risk factor, a mediator or a bystander in the pathogenesis of atrial fibrillation?In: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 34, 2021, 100818DOI (Open Access)
-
Implantable cardioverter-defibrillator therapy in primary versus secondary prevention : Reliable prediction of appropriate therapies and mortality is still an unmet needIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 32, 2021, S. 100740DOI (Open Access)
-
Nitric oxide as a fragile switch between cardioprotection and cardiac injuryIn: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 343, 2021, S. 102 – 103
-
Obstructive respiratory events during procedural sedation and analgesia : Another WHY to routinely screen for sleep apnea before catheter ablation of atrial fibrillationIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 33, 2021, 100783DOI (Open Access)
-
One Ring to Rule Them All : Continuous Monitoring of Patients With Secondary Atrial Fibrillation Points to a Unifying Underlying MechanismIn: Canadian Journal of Cardiology. Amsterdam: Elsevier, Jg. 37, 2021, Nr. 5, S. 686 – 689
-
Oral anticoagulation and therapy of atrial flutter : Discontinuation of anticoagulation revisitedIn: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 333, 2021, S. 117 – 118
-
Oxidative stress: a baystander or a causal contributor to atrial remodelling and fibrillation?In: Cardiovascular Research. Oxford: Oxford University Press (OUP), Jg. 117, 2021, Nr. 11, S. 2291 – 2293DOI (Open Access)
-
Personalized management of sleep apnea in patients with atrial fibrillation : An interdisciplinary and translational challengeIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 35, 2021, 100843DOI (Open Access)
-
Potential antiarrhythmic actions of anticoagulants : Do they exist and can they be clinically unmasked?In: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 331, 2021, S. 73 – 74
-
Proteomics : A promising approach to discover new biomarkers for atrial fibrillationIn: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 345, 2021, S. 125 – 126DOI, Online Volltext (Open Access)
-
Soluble fibrin monomer complex as a candidate sentinel for adverse events in patients with heart failureIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 32, 2021, S. 100712DOI (Open Access)
-
Stretching the limits of antiarrhythmic drug therapy : The promise of small-conductance calcium-activated potassium channel blockersIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 37, 2021, 100924DOI (Open Access)
-
Stroke prevention of atrial fibrillation : Improving geographic under-use of contemporary antithrombotic approaches remains a challengeIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 34, 2021, S. 100785DOI (Open Access)
-
The anticoagulation dilemma and future treatment avenues in patients with breast cancer and atrial fibrillationIn: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 323, 2021, S. 194 – 196
-
Therapy-refractory AF : A clear unmet need for the development of novel antiarrhythmic drugsIn: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 331, 2021, S. 114 – 115
-
Contemporary plaque imaging for risk stratification of coronary artery disease : Are we getting there?In: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 31, 2020, S. 100678DOI (Open Access)
-
Coronary clot composition after myocardial infarction : Thrombus age mattersIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 26, 2020, S. 100450DOI (Open Access)
-
Electrocardiographic sex-related differences in patients with atrial fibrillation : Do they allow a better risk stratification?In: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 307, 2020, S. 73 – 74
-
Heart failure with preserved ejection fraction meets atrial fibrillation : Is enhanced inflammasome signaling a major common mechanism leading to these two frequent diseases?In: Heart Rhythm. New York: Elsevier, Jg. 17, 2020, Nr. 6, S. 1034 – 1035
-
One for all and all for one? : The dilemma of optimal management of atrial fibrillation with cardiac co-morbiditiesIn: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 299, 2020, S. 175 – 176
-
Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction?In: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, 2020, Article-No: 100508DOI (Open Access)
-
Polypill revisited – Unity in diversityIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 29, 2020, S. 100607DOI (Open Access)
-
Recurrence of atrial fibrillation following non-cardiac surgery or acute illness : A common but rarely detected complicationIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 29, 2020, S. 100609DOI (Open Access)
-
The gut microbial-derived metabolite trimethylamine N-oxide : A missing link between lifestyle-components and atrial fibrillation?In: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 29, 2020, S. 100581DOI (Open Access)
-
Anticoagulation in difficult settings RELOADed : Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancerIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 23, 2019, S. 100374DOI (Open Access)
-
Atrial Ca²⁺/calmodulin-dependent protein kinase II : A druggable master switch of atrial fibrillation-associated atrial remodeling?In: Heart Rhythm. New York: Elsevier, Jg. 16, 2019, Nr. 7, S. 1089 – 1090
-
Atrial fibrillation in sub-Saharan Africa : The knowns and unknowns?In: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 22, 2019, S. 212 – 213DOI (Open Access)
-
Bound to bleed: How altered albumin binding may dictate warfarin treatment outcomeIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 22, 2019, S. 214 – 215DOI (Open Access)
-
Genome-wide association studies of atrial fibrillation : Finding meaning in the life of risk lociIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 24, 2019, S. 100397DOI (Open Access)
-
Highlights from the II International Journal of Cardiology Heart & Vasculature : Heart failure, atrial fibrillation, coronary artery disease and myocardial infarctionIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 25, 2019, S. 100443DOI (Open Access)
-
Outcome of atrial fibrillation ablation in pulmonary hypertension : Is pulmonary hypertension a modifiable risk factor?In: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 23, 2019, S. 100360DOI (Open Access)
-
Prognostic value of biomarkers of impaired metabolism in heart failure patients with reduced ejection fractionIn: International Journal of Cardiology (IJC) Heart & Vasculature. Amsterdam; Amsterdam; Amsterdam [u.a.]; Shannon: Elsevier, Jg. 25, 2019, S. 100441DOI (Open Access)
-
Pro-arrhythmic RyR2 channels in heart failure : Do their localisation and mechanism of activation really matter?In: Cardiovascular Research. Oxford: Oxford University Press (OUP), Jg. 114, 2018, Nr. 11, S. 1428 – 1429DOI (Open Access)
-
Prognostic impact of electrical storm in patients with implantable cardioverter defibrillators : mechanistic and therapeutic considerations to reduce the risk of deathIn: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 255, 2018, S. 101 – 102DOI, Online Volltext (Open Access)
-
Targeting atrial fibrillation promoting atrial structural remodeling : is this a viable strategy in patients with heart failure?In: Naunyn-Schmiedeberg's Archives of Pharmacology. Berlin: Springer, Jg. 391, 2018, Nr. 3, S. 231 – 233DOI (Open Access)
-
Dynamic balance of platelet reactivity in atrial fibrillation PARtially unravelledIn: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 243, 2017, S. 272 – 273
-
Hyperuricemia : a causal player or a bystander linking inflammatory signaling and atrial fibrillation?In: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 231, 2017, S. 177 – 178
-
Role of triggers and substrate in heart failure based atrial fibrillation : is pulmonary vein isolation still the cornerstone of atrial fibrillation therapy?In: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 243, 2017, S. 276 – 278
-
Targeting supraventricular ectopic complexes : which approach should be used and how does it affect atrial fibrillation?In: International Journal of Cardiology. Amsterdam: Elsevier, Jg. 244, 2017, S. 202 – 203DOI (Open Access)
-
Unique cardiomyocyte ultrastructure in atria : role of T tubules in subcellular Ca²⁺ signaling and atrial arrhythmogenesisIn: Heart Rhythm. New York: Elsevier, Jg. 14, 2017, Nr. 2, S. 282 – 283
-
Atrial arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia – is there a mechanistic link between sarcoplasmic reticulum Ca2+ leak and re‐entry?In: Acta Physiologica. Weinheim: Wiley-Blackwell, Jg. 207, 2013, Nr. 2, S. 208 – 211
-
KCNQ1 autoantibodies : another way to regulate IKsIn: Cardiovascular Research. Oxford: Oxford University Press (OUP), Jg. 98, 2013, Nr. 3, S. 329 – 331
-
Computational Modeling Identifies Estrogen Protective Mechanisms Against Atrial FibrosisIn: Circulation Research. New York; Philadelphia; Baltimore: Lippincott Williams and Wilkins, Jg. 137, 2025, Nr. Suppl_1, Fri161
-
Oxidazed LDL and LOX-1 mediates Atrial Fibrillation in Chronic Kidney DiseaseIn: Circulation Research. New York; Philadelphia; Baltimore: Lippincott Williams and Wilkins, Jg. 137, 2025, Nr. Suppl_1, Fri085
-
Computational modeling identifies increased background Ca2+ influx as a potential promoter of arrhythmogenic Ca2+ instability in atrial fibrillationIn: Biophysical Journal. Amsterdam: Elsevier, Jg. 123, 2024, Nr. 3, Suppl. 1, S. 384A – 384A
-
Macrophage-mediated interleukin-6 signaling drives ryanodine receptor-2 calcium leak in postoperative atrial fibrillation
European Society of Cardiology Congress (ESC) 2024, 30 August – 02 September 2024, London, UK,In: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 45, 2024, Nr. Supplement 1, ehae6663765 -
Sex-specific contribution of small-conductance Ca2+-activated K+ current to atrial electrophysiology and arrhythmogenesisIn: Biophysical Journal. Amsterdam: Elsevier, Jg. 122, 2023, Nr. 3, Supplement 1, S. 382A
-
Upregulation of protease-activated receptors contributes to the molecular atrial substrate associated with post-operative atrial fibrillation (POAF)
8th German Pharm-Tox Summit 2023, 06.-09.03.2023, Ulm,In: Naunyn-Schmiedeberg's Archives of Pharmacology. Berlin: Springer, Jg. 396, 2023, Nr. Supplement 1: 8th German Pharm-Tox Summit 2023 Abstracts of the 89. Jahrestagung der Deutschen Gesellschaft für Experimentelle und Klinische Pharmakologie und Toxikologie (DGPT) in Zusammenarbeit mit der AGAH, S. S42 – S43DOI (Open Access) -
A Modeling Framework for Investigating the Role of Human Atrial Fibroblast Calcium Signaling in FibrogenesisIn: Biophysical Journal. Amsterdam: Elsevier, Jg. 120, 2021, Nr. 3, Supplement 1, S. 53a – 54aDOI (Open Access)
-
Increased FDG uptake in AF individuals suggesting atrial inflammation visualized by FDG PET/CT with glucose uptake suppression protocolsIn: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 42, 2021, Nr. Supplement_1, ehab724.0324DOI (Open Access)
-
Thrombin receptor PAR4 coordinates inflammatory stress platforms in diabetic atria
87th Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) ; 1 March – 3 March 2021, Digital,In: Naunyn-Schmiedeberg's Archives of Pharmacology. Berlin: Springer, Jg. 394, 2021, Nr. Suppl. 1, S. S6DOI (Open Access) -
Abnormal cellular electrophysiology and calcium handling in iPSC-CMs from a patient with tetralogy of Fallot
84th Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) and the 20th Annual Meeting of the Association of the Clinical Pharmacology Germany (VKliPha) ; 26 February – 1 March 2018. Göttingen,In: Naunyn-Schmiedeberg's Archives of Pharmacology. Berlin: Springer, Jg. 391, 2018, Nr. 1, Supplement, S. S18 -
Effects of Modulation of Small-Conductance Calcium-Activated Potassium Current on Atrial Electrophysiology and Arrhythmogenesis : A Population-Based Computational Study
62nd Annual Meeting of the Biophysical Society ; February 17-21, 2018, San Francisco,In: Biophysical Journal. Amsterdam: Elsevier, Jg. 114, 2018, Nr. 3, Suppl. 1, S. 473aDOI (Open Access) -
Proarrhythmic Subcellular Signaling in Atrial Fibrillation : Role of Calcium Dependent Potassium Channels
23rd World Congress on Heart Disease, 27-29July 2018, Boston,In: Cardiology. Basel: Karger, Jg. 140, 2018, Nr. Suppl. 1, S. 79DOI (Open Access) -
P678: S-glutathiolation of cMyBP-C reduces its phosphorylation and contributes to impairment of cardiac myocyte contractile functionIn: Cardiovascular Research. Oxford: Oxford University Press (OUP), Jg. 103, 2014, S. S123 – S124DOI (Open Access)
-
New antiarrhythmic drugs and new targets for antiarrhythmic drugsIn: Antiarrhythmic Drugs / Martínez-Rubio, Antoni; Tamargo, Juan; Dan, G.-Andrei (Hrsg.). Cham: Springer Nature, 2024, S. 283 – 310
-
ArrhythmiasIn: Comprehensive Pharmacology: Volume 4: Endocrinology, Cardiovascular, Hematopoietic, Urinary and Respiratory Pharmacology / Kenakin, Terrence P.; Michel, Martin C.; Bewick, Gavin. San Diego: Elsevier, Jg. 4, 2022, S. 432 – 468
-
Cardiac Inflammasome and ArrhythmiaIn: Cardiovascular Signaling in Health and Disease / Parinandi, Narasimham L.; Hund, Thomas J.. Cham: Springer International Publishing, 2022, S. 259 – 285
-
The Molecular Pathophysiology of Atrial FibrillationIn: Cardiac Electrophysiology: From Cell to Bedside / Zipes, Douglas P.; Jalife, José; Stevenson, William G. (Hrsg.). Philadelphia, PA: Elsevier, 2018, S. 396 – 408
-
Cholinergic and Constitutive Regulation of Atrial Potassium ChannelIn: Cardiac Electrophysiology: From Cell to Bedside / Zipes, Douglas P.; Jalife, José. Philadelphia, Pa.: Elsevier Inc., 2014, S. 383 – 391
-
Constitutive Activity of the Acetylcholine-Activated Potassium Current IK,ACh in CardiomyocytesIn: Pharmacology & Therapeutics of Constitutively Active Receptors / Tao, Ya-Xiong (Hrsg.). Burlington: Elsevier Science, 2014, S. 393 – 409
-
The Molecular Pathophysiology of Atrial FibrillationIn: Cardiac Electrophysiology: From Cell to Bedside / Zipes, Douglas P.; Jalife, José (Hrsg.). Philadelphia, Pa.: Elsevier Inc., 2013, S. 449 – 458